Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,625.00    -50.00 (-1.07%)
Bid:
4,500.00
Ask:
4,750.00
Spread: 250.00 (5.556%)
Market Cap: £308.06m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

10 Jun 2009 07:00

RNS Number : 6409T
Judges Scientific PLC
10 June 2009
 

10 June 2009

JUDGES SCIENTIFIC plc

("Judges Scientific" or the "Company")

ACQUISITION OF QUORUM TECHNOLOGIES LIMITED

Judges Scientific (formerly Judges Capital plc)the parent company of a group that specialises in the design, manufacture and sale of scientific instruments, announces that it has today completed the acquisition of the entire issued share capital of Quorum Technologies Limited ("Quorum" or the "Acquisition") for a total consideration of up to £1.5 million. 

Quorum designs manufactures and distributes sample preparation instruments for use in electron microscopy. Imaging in electron microscopy generally requires samples to be electrically conductive in order to prevent a build up of electrical charges which would adversely affect the clarity of images. Typical sample preparation will involve some combination of cleaning, drying, coating or freezing prior to samples being introduced into the vacuum chamber of an electron microscope. Instruments produced by Quorum for sample freezing ("cryo") and transfer under vacuum are manufactured at the company's plant in Ringmer, East Sussex, while those used to coat non-cryo samples are primarily produced at its site in Ashford, Kent.

Quorum's products are marketed principally under the Polaron and Emitech brand names. Customers include many of the world's leading universities and research and forensic laboratories, as well as the major manufacturers of electron microscopes. Applications for the technology are to be found in all the life and materials sciences, as well as cutting-edge industrial technologies such as semiconductor production.

Quorum was founded in 2001 by Bob Kenhard and three colleagues through the purchase of a small business engaged in the manufacture of the Polaron range of sample preparation instruments from VG Systems Limited, a wholly-owned division of Thermo Electron CorporationPolaron is a widely respected brand in the field of electron microscopyhaving been established at the vanguard of the growth in this technology during the 1960s. In 2005, Quorum acquired the assets and trade of Emitech Limited, a major UK competitor and a significant brand in sample preparation.

Mr Kenhard, aged 61, will remain with Quorum for a period of up to a year as Managing Director and thereafter as consultant to ensure a smooth transition before his eventual retirement.

 

Quorum's audited accounts for the year ended 31 October 2008 show sales of £4.0 million, the majority of which was exported, on which the company generated operating profits of £749,000. Net tangible assets as at 31 October 2008 amounted to £1.1 million. Quorum's operating profits figure of £749,000 includes a number of items which, had Quorum been a part of the Judges Scientific group of companies during that financial year, would not have been included. The Board of Judges Scientific believes that the exclusion of such items would have resulted in a lower operating profit for Quorum of approximately £496,000The Board expects the Acquisition to be earnings-enhancing in the current year.

The initial consideration for the Acquisition being paid by Judges is £1.2 million in cash. An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Further consideration will be payable to the vendors based on Quorum's earnings before interest and tax ("EBIT") in the twelve months following completion; under this earnout arrangement, the vendors will receive three times the amount by which Quorum's EBIT exceeds £400,000 up to a maximum payment of £300,000.

The Acquisition has been financed out of surplus funds. The Bank of Scotland has agreed (subject to the finalisation of documentation) to make available to Judges Scientific a £4 million term loan, of which £3 million will be drawn down to refinance this acquisition and to refinance the Company's existing borrowing, of which approximately £1.7 million remains outstanding. The additional £1 million is conditionally available to be drawn down in the event of further M&A activity. In addition, a £500,000 overdraft facility will continue to be available to the Company.

Alex Hambro, Chairman of Judges Scientific, commented: "I am delighted that we have acquired this attractive business without issuing shares and without incurring imprudent levels of debt. It is important to pursue our strategy of enhancing earnings through the acquisition of niche businesses in our sector while adjusting our short term ambitions to the realities of today's financial environment."

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Shore Capital:     Tel: 020 7408 4090

Melvyn Marckus, Cardew Group:  Tel: 07775 896 491

Web sites:

Judges Scientific: www.judges.uk.com 

Quorum: www.quorumtech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUKUWRKNRNRAR
Date   Source Headline
6th Oct 201711:23 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSInterim Results for the 6M ended 30 June 2017
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:08 amRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:11 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSNotice of Results
21st Jul 20179:51 amRNSDirector/PDMR Shareholding
21st Jul 20179:20 amRNSHolding(s) in Company
20th Jul 20171:57 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSTrading Update and Notice of Interim Results
18th Jul 20177:00 amRNSAcquisition
6th Jul 20174:15 pmRNSDirector/PDMR Shareholding
6th Jul 20174:12 pmRNSDirector/PDMR Shareholding
6th Jul 20174:11 pmRNSDirector/PDMR Shareholding
7th Jun 20172:49 pmRNSDirector/PDMR Shareholding
7th Jun 20172:48 pmRNSDirector/PDMR Shareholding
7th Jun 20172:46 pmRNSDirector/PDMR Shareholding
5th Jun 201711:31 amRNSHolding(s) in Company
24th May 201712:52 pmRNSResult of Annual General Meeting
15th May 20177:00 amRNSBlocklisting Return
10th May 20173:39 pmRNSDirector/PDMR Shareholding
10th May 20173:38 pmRNSDirector/PDMR Shareholding
10th May 20173:36 pmRNSDirector/PDMR Shareholding
10th May 20173:35 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20175:10 pmRNSDirector/PDMR Shareholding
7th Apr 20178:57 amRNSDirector/PDMR Shareholding
7th Apr 20178:55 amRNSDirector/PDMR Shareholding
7th Apr 20178:54 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
21st Mar 20177:00 amRNSFinal Results
8th Mar 20172:41 pmRNSDirector/PDMR Shareholding
8th Mar 20172:40 pmRNSDirector/PDMR Shareholding
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
8th Feb 20173:50 pmRNSDirector/PDMR Shareholding
8th Feb 20173:45 pmRNSDirector/PDMR Shareholding
8th Feb 20173:40 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
23rd Jan 20177:00 amRNSTrading statement and Notice of Final Results
10th Jan 201712:10 pmRNSDirector/PDMR Shareholding
10th Jan 201712:05 pmRNSDirector/PDMR Shareholding
10th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
15th Dec 201611:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.